Last Updated on February 24, 2026
Skin reprogramming could be the future of curing or reversing the effects of diabetes. “Skin reprogramming” might sound like something out of a sci-fi novel, but it is something that is being tested now. According to a journal released in Nature Communications, several scientists have begun to reprogram human cells to produce insulin.
The scientists took skin from the recently circumcised new boy males. The skin is usually discarded, but these researchers used it for research purposes. The researchers are using the skin to alter the beta cells inside of it.
So far the researchers in the study have boasted impressive results, they haven’t tested the reprogramming in humans yet. The technique of reprogramming has shown remarkable results when tested inside of lab dishes in a controlled environment. The altered skin has also performed well inside of laboratory rats.
After implanted this programmed skin cells into mice with diabetes. After just one week, the mice’s glucose levels began to approach normal levels (for a mice). Even more importantly, after eight weeks the mice began to show improved levels of beta cells, an important part of improving type 1 diabetes. If these results continue and can be repeated, the research groups with hopefully receive approval to test using human trials. The tests using humans will be the indicator of the reprogrammed having a positive effect on diabetics. But mice and controlled lab dishes react differently than the complex human body.
<>While the cells have seen to show improvement in these conditions, the scientists say there could be a few complications with the reprogramming. The modified cells are not identical to those found naturally inside of the body. There are a few slight differences with the alternated ones compared to the natural insulin pancreatic cells. These new cells are not as potent at releasing insulin as matured beta cells are.
The researchers also went on to say that aside from the minor differences, there is hope that the modified cells can help type 2 diabetics, but they are skeptical about the impact it will have on type 1 diabetics. The cells on them own would likely be destroyed by the immune system in the body. Other research projects are working to “hide” these modified cells so they will not be detected by the body. If these cells can survive inside of the body, it’s thought that they will mature enough to produce beta cells to encourage insulin creation and release.
With reprogrammed cells, there is a chance that the cells be programmed incorrectly leading to health complications. With these programmed cells, this is only a minimal chance compared to other reprogrammed cells. For type 1 diabetics the risk is minimal, but the reward is incredible. As more programming of cells occurs, the risk of the procedure will continue to decrease.
The idea of using the reprogrammed cells to cure diabetes is a new idea. The studies are still in the infant stage and only time will tell if it is a plausible idea. As the research continues to show results, this could be a huge advancement in finding a cure for both type 1 and type 2 diabetics and other chronic diseases. Reprogramming is also being tested to cure different types of cancers.
This testing is still in the early stages, but could have a huge impact on the way that we look at diabetics and the way researchers approach treatments. Even if the skin reprogramming isn’t the answer to curing diabetes, it’s a significant step towards understanding the workings of the complex disease.
